157 related articles for article (PubMed ID: 3204075)
1. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Moffie BG; Mouton RP
J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
[TBL] [Abstract][Full Text] [Related]
2. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
Barker JE; Farrell ID
J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
[TBL] [Abstract][Full Text] [Related]
3. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Onody C; Matsiota-Bernard P; Nauciel C
J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Nielsen K; Bangsborg JM; Høiby N
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
7. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.
Pendland SL; Killian AD; Woodward JG; Rodvold KA
J Antimicrob Chemother; 1997 May; 39(5):651-3. PubMed ID: 9184367
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
13. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.
Kitsukawa K; Hara J; Saito A
J Antimicrob Chemother; 1991 Mar; 27(3):343-53. PubMed ID: 2037540
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Edelstein PH; Gaudet EA; Edelstein MA
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
[TBL] [Abstract][Full Text] [Related]
17. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
Walz A; Nichterlein T; Hof H
Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
[TBL] [Abstract][Full Text] [Related]
19. The effect of antibiotics that inhibit cell-wall, protein, and DNA synthesis on the growth and morphology of Legionella pneumophila.
Rodgers FG; Tzianabos AO; Elliott TS
J Med Microbiol; 1990 Jan; 31(1):37-44. PubMed ID: 2296040
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]